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ABSTRACT 
Objective: This study obtained information on Paracetamol (PCM) Dispensing Practice of Government Health Clinics (GHC) post infants’ vaccination 
in Malaysia as well as identify its possible factors.  
Methods: This descriptive cross-sectional retrospective study (with convenient sampling) using a data collection form (DCF) to collect data. The 
pharmacist who is the representative of the GHC filled the DCF. Potential risk factors were evaluated by Pearson chi-square tests (expected count<5 
is<20%) for an independent sample.  
Results: A total number of 254 samples were collected all over Malaysia within the period of data collection, but only 248 that met inclusion 
criteria. The PCM dispensing practice of GHC in Malaysia for a total period of 3 y back (from 2015-2017), tend not to give PCM post-immunization 
with respect to age of the upon vaccination and types of vaccination, conversely for gender. Trends of PCM dispensing practice were increasing for 
“Not Give PCM” with respect to gender, age of the baby upon vaccination, and types of vaccination from 2015 till 2017. The PCM dispensing practice 
had no association with no statistically significant value (p=0.804) on genders and a weak positive association with statistically significant value 
(p<0.05 each) on age of the baby (≤ 1year) upon vaccination and types of vaccination.  
Conclusion: Future research which may include the actual practice in which practices of prescribers or mother may be conducted in determining 
more accurate data on the giving PCM post infant’s vaccination.  
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Increased utilization of paracetamol (PCM) for the prevention and 
treatment infant post-vaccination has received widespread attention 
in the past decade. This attention is reflected in news coverage of 
research as well as in its safety issues [1]. Paracetamol use post 
infants’ vaccination not only may cause the vaccine less effective [1], 
but also its use in infancy and childhood was associated with the 
development of asthma, rhinoconjunctivitis, and eczema in 6-to 7-
year-old children, where the associations seemed to be dose-
responsive for childhood paracetamol exposure [2]. However, until 
today, there are no updated clinical practice standards worldwide. 
Generally, there are no data regarding PCM dispensing practice post 
infant’s vaccination available worldwide for baseline reference. In 
Malaysia, the government health clinics (GHC) usually dispense PCM 
post infants vaccination according to the current recommendations 
of both the American Academy of Pediatrics in 2003 [3] and the 
Advisory Committee on Immunization Practices (ACIP) in 2002 [4] 
as well as College of Paediatrics, Academy of Medicine of Malaysia in 
2001 [5] and the Public Health Department, Ministry of Health 
Malaysia (PHD, MOH) in 2008 [6] note the option to give PCM 
prophylaxis for childhood vaccinations, but neither promote nor 
discourage routine use of prophylaxis [7]. Other than that, the 
statement from the American Academy of Pediatrics, 2003 stated 
that ‘Elective administration of acetaminophen or other appropriate 
antipyretic at the time of immunization with DTaP and at 4 and 8 h 
after immunization may decrease the subsequent incidence of fever 
and local reactions’ [3]. The statement from the Advisory Committee 
on Immunization Practices (ACIP), 2002 stated that ‘Acetominophen 
has been used among children to reduce the discomfort and fever 
associated with vaccination [4].  
In Malaysia, national guideline stated that ‘Paracetamol is used in 
helping relieving discomfort because of local reactions post-
vaccination. Paracetamol also is used to reduce unpleasant systemic 
symptoms’ [5]. ‘Paracetamol may be given before or after 
vaccination and repeated every 4-6hourly as required’ [5]. ‘The dose 
of Paracetamol is 15 mg/kg body weight, per dose, up to a maximum 
of 5 doses in 24h’. The statement from the PHD, MOH, 2008 stated 
that ‘Paracetamol 15 mg/kg/dose for every 4-6h is included in the 
adverse events management of Diphtheria, Pertussis and Tetanus 
(DPT) (for fever<38.5 °C which occurs within 48h after 
immunization), Measles/Measles, Mumps, and Rubella (MMR) (for 
fever which occurs 6-10d after immunization) and Rubella (for fever 
which occurs within 3w after immunization) vaccination’. 
However, some general and private health clinics in Malaysia may 
show different for PCM dispensing practices post all types of infant’s 
vaccination regardless of age of the baby upon vaccination and 
gender, generally. Meanwhile, some of them dispensed based on 
types of vaccination. Thus, the data regarding the practices of PCM 
post infant’s vaccination need to be collected and analyzed from 
both private and government settings.  
This study aims to study the current practice on the use of PCM post 
infant’s vaccination in Malaysia. Up to the researcher knowledge, to 
date, the extent of the patterns of PCM dispensing practice for 
treatment or prophylaxis post infant’s vaccination in community 
settings with local samples not yet was reported. This study also 
identifies the possible factors for PCM dispensing practice post 
infant’s vaccination of GHC in Malaysia. 
Immunization is compulsory for those babies seen as GHC. The 
researchers sought to study the PCM dispensing practices post 
infants vaccination at GHC in Malaysia.  
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MATERIALS AND METHODS 
Methods 
Study design and time frame 
This is a retrospective cross-sectional study that obtained secondary 
data from GHC on the PCM dispensing practice in Malaysia from 
2015 to 2017. The datum was collected conveniently by email and 
follow-up by phone calls between December 2017 to September 
2018. This study was used to characterize the PCM dispensing 
practice patterns post infants vaccination. Trends were depicted as 
the total of 3 y periods of study percentage for PCM dispensing 
practice post infants’ vaccination according to age of the baby upon 
vaccination, gender and types of vaccination. 
Data sources  
A letter was sent to each State Health Department, Ministry of 
Health Malaysia to obtain approval for the collection of data 
regarding PCM dispensing practice post infants’ vaccination. 
A descriptive data collection form (DCF) was used to collect data 
related to the objectives of this study was created by the researcher 
and reviewed by experts. The DCF comprised 2 sections. The first 
section included the name and address of the Mother and Child 
Health (MCH) Clinics involved, date of data collected as well as name 
of the pharmacist in charged. The second section of the DCF was 
information about PCM dispensing practice of each clinic for the 
studied year, 2015 till 2017 with regards to the age of the baby upon 
vaccination, gender and types of vaccination. The data collected 
were based on the experience of healthcare professionals in the GHC 
in Malaysia. 
Population and sample  
This study involved five types of vaccines based on Malaysian 
Immunization Programme for infants from 2015 till 2017. The 
populations include the babies up to 1 y of age who received the 
vaccination at GHC in Malaysia. The study subjects were the 
pharmacist of the GHC (that had attached MCH clinics).  
Inclusion and exclusion criteria 
The inclusion criteria were age of the baby up to one year who 
received immunization at GHC that had attached MCH Clinics and 
pharmacist. Incomplete data on the age of the baby upon vaccination 
and gender and types of vaccination will be excluded in this study. 
Sample with incorrect data such as gave the reported number of 
prescriptions prescribed also excluded in this study. Sample 
collected from Rural Health Clinics (RHC) also were excluded 
because there was no pharmacist in charge there. The Measles 
vaccine also will be excluded since it is given before age one year in 
Sabah only. 
Sample size calculation  
The estimated samples are calculated via Rao soft Software (2004). 
The sample size n and margin of error E are given by:  
r)-(100Z(c/100)2r=x  
 x)+ 1)E2- x/((NN=n  
1)]-n)x/n(N - Sqrt[(N=E     
 
Where N is the population size, r is the fraction of responses that the 
researcher interested in, and Z(c/100) is the critical value for the 
confidence level c.  
This calculation is based on the normal distribution and assumes 
this study has more than about 30 samples. This calculation is also 
based on the agreement of margin of error of 5%, Confidence 
Interval of 95%, Population Size of 692 and Response Distribution is 
50%. We need to obtain n=248 samples of the pharmacist. 
According to personal communication, via the person in charge of 
each district, there were a total of 692 GHC that had attached MCH 
Clinics as well as a pharmacist in charge in Malaysia. Among them, a 
total of calculated samples of 248 pharmacists were included in this 
study during the study period. The data collection for this study took 
about 10 mo for an estimated 248 approved samples of pharmacists. 
One DCF for one clinic. These samples met inclusion criteria for this 
present research. 
Variables (Independent and dependent) 
The DCF collected dependent variables which include PCM 
dispensing practice post infants’ vaccination in Malaysia (either give 
PCM, not give PCM or not sure/don’t know), meanwhile the 
independent variable collected include gender, age of the baby upon 
vaccination and types of vaccination.  
Statistical analysis 
Descriptive statistics using frequency and percentages were used to 
report the PCM dispensing practice of MCH Clinics in Malaysia based 
on the age of the baby upon vaccination, gender and types of 
vaccination. They present into bar chart using Microsoft Excel 2013. 
The difference in the bar chart may give a brief idea on PCM 
dispensing practice post infants vaccination.  
This study explored the age of the baby upon vaccination, gender 
and types of vaccination received as well as identified the possible 
factors for PCM dispensing practice post infant’s vaccination in 
Malaysia retrospectively from 2015 till 2017 using the Crosstabs 
function in SPSS Statistics Version 22.0. Potential risk factors were 
evaluated by Pearson chi-square tests (expected count<5 is<20%) 
for an independent sample. The hypotheses are as below:  
H0: There is no association between age of the baby upon 
vaccination, gender and types of vaccination towards PCM practice 
post infant’s vaccination.  
Ha: There is an association between age of the baby upon 
vaccination, gender and types of vaccination towards PCM practice 
post infant’s vaccination.  
This study assumed a significance level at a p-value less than 0.05. 
[8] The data were managed and analysis conducted using SPSS 
Statistics version 22. This study followed Cohen (1988) 
recommendations in the interpretation of effect size for behavioral 
sciences which stated that there is a statistically significant measure 
with a small effect size or greater to indicate difference for the study. 
The researcher used Phi Coefficient for correlation coefficients in 
determining whether the factors showed-1.0 to-0.7 or-0.7 to-0.3 or-
0.3 to+0.3 or+0.3 to+0.7 or+0.7 to+1.0 which is interpreted as strong 
negative association or weak negative association or little or no 
association or weakly positive association or strong positive 
association respectively [9]. These values of analyses of statistics 
may be important in giving the baseline data on possible 
associations on the PCM dispensing practice post infants’ 
vaccination.  
RESULTS AND DISCUSSION 
A total number of 254 samples were obtained from all over Malaysia 
within period of data collection, but only 248 respondents 
(pharmacists) included in this study since the other 6 samples 
received did not meet the inclusion criteria of this study in which 1 
of them reported number of prescriptions and the other 5 were 
reported from RHC. 
Trends of paracetamol dispensing practice 
Total data collected from DCF for gender category was N=1488, age 
of the baby upon vaccination category revealed N=5852 and types of 
vaccination category discovered N=2976 responses while each 
group collected N=744 responses. 
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Data collection details 
 
Table 1: Region of data collection 




Number of respondents that met 
inclusion criteria 
Response rate of approved 
respondents (%) 
Johor State Health 
Department 
91 75 74 81.32 
Negeri Sembilan State Health 
Department 
49 20 20 40.82 
Melaka State Health 
Department 
27 10 10 37.04 
Selangor State Health 
Department 
65 43 43 66.15 
Perak State Health 
Department 
2 0 0 0 
Perlis State Health 
Department 
9 9 9 100 
Kedah State Health 
Department 
55 24 24 43.64 
Penang State Health 
Department 
27 0 0 0 
Kelantan State Health 
Department  
158 35 30 18.99 
Terengganu State Health 
Department 
43 0 0 0 
Pahang State Health 
Department 
58 20 20 34.48 
Sabah State Health 
Department 
46 0 0 0 
Sarawak State Health 
Department 
44 18 18 40.91 
Total 692 254 248 35.84 































Fig. 1: Trends of paracetamol dispensing practice for respective years according to gender 
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Table 2: Paracetamol dispensing practice for 3 y period of study (viz. 2015-2017) 
Variables  Paracetamol dispensing practice Frequencies, n 
Gender   1488 
 Female  744 
  Give PCM 361 
  Not Give PCM 306 
  Not Sure/Don’t Know 77 
 Male  744 
  Give PCM 373 
  Not Give PCM 294 
  Not Sure/Don’t Know 77 
Age of the Baby Upon Vaccination    5852 
 0 mo BCG  744 
  Give PCM 70 
 Not Give PCM 552 
 Not Sure/Don’t Know 122 
 0 mo Hepatitis B  744 
  Give PCM 77 
  Not Give PCM 551 
  Not Sure/Don’t Know 116 
 1 mo Hepatitis B  744 
  Give PCM 133 
  Not Give PCM 564 
  Not Sure/Don’t Know 47 
 6 mo Hepatitis B  744 
  Give PCM 151 
  Not Give PCM 544 
  Not Sure/Don’t Know 49 
 3 mo DTaP/Hib/IPV  744 
  Give PCM 395 
  Not Give PCM 300 
  Not Sure/Don’t Know 49 
 3 mo DTaP/Hib/IPV  744 
  Give PCM 380 
  Not Give PCM 312 
  Not Sure/Don’t Know 52 
 5 mo DTaP/Hib/IPV  744 
  Give PCM 385 
  Not Give PCM 310 
  Not Sure/Don’t Know 49 
 12 mo MMR  744 
  Give PCM 250 
  Not Give PCM 437 
  Not Sure/Don’t Know 57 
Types of Vaccination    2976 
 BCG  744 
  Give PCM 95 
 Not Give PCM 550 
 Not Sure/Don’t Know 99 
 Hepatitis B  744 
  Give PCM 148 
  Not Give PCM 545 
  Not Sure/Don’t Know 51 
 MMR  744 
  Give PCM 249 
  Not Give PCM 443 
  Not Sure/Don’t Know 52 
 DTaP/Hib/IPV  744 
  Give PCM 394 
  Not Give PCM 299 
  Not Sure/Don’t Know 51 
n=total number of babies; different babies across gender, age of babies upon vaccination and types of vaccination included in this study. Thus, 
multiple logistic regression cannot be done. 
 
N=248; total number of DCF distributed among subjects in this 
study. Since the data collected were for 3 consecutive years, (2015-
2017) thus, the total available samples for each item in different 
variables were 744.  
These were retrospective data (2015-2017) collected conveniently 
by email and follow-up by phone calls between December 2017 to 
September 2018; based on experience of a representative of 
healthcare professionals in the GHC in Malaysia. The data collected 
might not be accurate because the healthcare professionals in 
charged might be different every year. 
Table 2 showed that PCM dispensing practice of GHC in Malaysia for 
a total period of 3 y back, tends not to give PCM post immunization 
with respect to age of the baby upon vaccination and types of 
vaccination. This result also suggested that the age of the baby upon 
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vaccination and types of vaccination possible factors for PCM 
dispensing practice post infant’s vaccination of GHC in Malaysia. 
Gender was not a possible factor of PCM dispensing practice since it 
showed moderate percentages between “give PCM” and “not give 
PCM” (table 2). Additionally, there was very little discrepancy in the 
counts across genders, contrary there was considerable discrepancy 
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Fig. 3: Trends of paracetamol dispensing practice for respective years according to types of vaccination 
 
Refer to fig. 1 till 3 for year 2015 till 2017, according to gender, age of the 
baby upon vaccination and types of vaccination, the trends of PCM 
dispensing practice was increasing for “Not Give PCM” and on the other 
hand it was decreasing for “Give PCM” over three years of 2015 till 2017 
(fig. 1-3). This might be due to the counterproductive effect of PCM on 
the vaccine injected which may cause the vaccine less effective. 
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 Factors associated with paracetamol dispensing practice 
 
Table 3: Factors associated with paracetamol dispensing practice 





























0.017 Small Not reject 
H0   Male 373 
 
294 77 
 Female 361 306 77 
Age of the Baby 
Upon 
Vaccination  











0.281 Small Reject H0 
 0 mo BCG 70 552 122 
 0 mo Hep B 77 551 116 
 1 mo Hep B 133 564 47 
 6 mo Hep B 151 544 49 
 2 mo 
DTaP/Hib/IPV 
395 300 49 
 3 mo 
DTaP/Hib/IPV 
380 312 52 
 5 mo 
DTaP/Hib/IPV 
385 310 49 
 12 mo MMR 250 437 57 
Types of 
Vaccination  











0.243 Small Reject H0 
 BCG 65 550 99 
 Hep B 148 545 51 
 MMR 249 443 52 
 DTaP/Hib/IPV 394 299 51 
aPearson Chi-Square test, significant at p<0.05, bSimon, 2010, cCohen, 1988  
 
This study proved that there is no association between gender and 
PCM dispensing practice of GHC in Malaysia post infant’s vaccination 
(p=0.804) with a small effect size (table 3). It also was found that 
there are weak positive associations between age of the baby upon 
vaccination as well as types of vaccination and PCM dispensing 
practice of GHC in Malaysia post infants’ vaccination (p<0.001 each) 
with small size effect (table 3). This finding concluded that there is 
an association between age of the baby upon vaccination and types 
of vaccination towards PCM practice post infant’s vaccination, 
however conversely for gender, there is no association between 
gender and PCM dispensing practice post infants’ vaccinate. 
CONCLUSION 
Trends in PCM dispensing practice of GHC were increasing for “Not 
Give PCM” and decreasing for “Give PCM” with respect to gender, age 
of the baby upon vaccination, and types of vaccination from 2015 till 
2017. The PCM dispensing practice had no association on genders 
(with a small effect size) as well as a weak positive association with 
age of the baby upon vaccination and types of vaccination (with a 
small effect size). This study may give a baseline data in the patterns 
of PCM dispensing practice post infants vaccination in Malaysia.  
LIMITATION 
The data collected might not be accurate because the healthcare 
professionals in charged might be different every year. In comparing 
the PCM dispensing practices post infants vaccination, the data 
might be more accurate if prescribers and infants mothers involved 
in the study.  
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